Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
D001777:Blood Coagulation / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D010973:Platelet Adhesiveness / Q000187:drug effects; D011134:Polysaccharides / Q000494:pharmacology / Q000627:therapeutic use*; D013916:Thrombelastography; D013927:Thrombosis / Q000517:prevention & control*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001798:Blood Proteins; D004338:Drug Combinations; D008055:Lipids; D008074:Lipoproteins; D009539:Nicotinic Acids; D010919:Placebos; D011134:Polysaccharides; D014280:Triglycerides; D002784:Cholesterol